Search / 508 results found

from
to

TUESDAY, Jan. 18, 2022 (HealthDay News) -- Residents of nursing homes have been a particularly high-risk group throughout the pandemic, and the advent of the fast-spreading omicron variant has them facing another wave of infections and deaths, new data show.

TUESDAY, Jan. 18, 2022 (HealthDay News) -- The latest shipment of 1.1 million COVID-19 vaccines to Rwanda this weekend signaled a noteworthy achievement: The COVAX program, a United Nations-backed program providing poorer countries with vaccines, has now shipped 1 billion of the doses to combat COVID-19 in 144 countries.

  • Updated

TUESDAY, Jan. 18, 2022 (HealthDay News) -- Before getting their first dose of a COVID vaccine, many Americans were nervous about how they would react to the shot, but new research shows that fears of side effects may actually make side effects more likely.

  • Updated

MONDAY, Jan. 17, 2022 (HealthDay News) -- The latest shipment of 1.1 million COVID-19 vaccines to Rwanda this weekend signaled a noteworthy achievement: The COVAX program, a United Nations-backed program providing poorer countries with vaccines, has now shipped one billion of the doses to combat the coronavirus in 144 countries.

MONDAY, Jan. 17, 2022 (HealthDay News) -- Residents of nursing homes have been a particularly at-risk group throughout the pandemic, and the advent of the fast-spreading Omicron variant has them facing another wave of infections and deaths, new data shows.

  • Updated

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 10 to 14, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.

  • Updated

FRIDAY, Jan. 14, 2022 (HealthDay News) -- Full COVID-19 vaccination, including third doses and/or boosters, is recommended for all patients with cancer, with a strong preference for mRNA vaccines, according to expert consensus recommendations published by the National Comprehensive Cancer Network (NCCN).

  • Updated

Could the 'mono' virus be a cause of MS? Researchers have long suspected that the Epstein-Barr virus might play a role in multiple sclerosis, and now a new study strengthens the case. Researchers found the risk of developing MS shot up 32-fold after infection. Read more